US Pharma MarketingFDA approves Ultragenyx's gene therapy Genglycos for glycogen storage disorder
Ultragenyx has secured its first approved gene therapy, with the FDA clearing its asset for an ultra-rare disease that can cause life-threatening blood sugar crashes. The FDA on Wednesday granted accelerated ...
Ultragenyx has secured its first approved gene therapy, with the FDA clearing its asset for an ultra-rare disease that can cause life-threatening blood sugar crashes.
The FDA on Wednesday granted accelerated ...
Source: Endpoints News